Vertex Pharmaceuticals Inc. buy Bank of America Co.
Start price
19.12.24
/
50%
€377.00
Target price
19.12.25
€503.63
Performance (%)
3.34%
End price
20.12.25
€389.60
Summary
This prediction ended on 20.12.25 with a price of €389.60. With a performance of 3.34%, the BUY prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc. closed with a slight gain. Bank_of_America_Co_ has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 6.051% | 6.051% | -4.212% |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Bank of America Co. from $545.00 to $522.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€456.50
31.03.25
31.03.25
€523.00
31.03.26
31.03.26
-12.08%
26.01.26
26.01.26
Stopped prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€444.75
14.10.24
14.10.24
€496.10
14.10.25
14.10.25
-20.33%
15.10.25
15.10.25